OSX.AU · Osteopore Limited

-

Please sign in to comment on OSX.AU

1 Comment

Admin

4 years, 1 month ago

Osteopore Limited is currently in a long term downtrend where the price is trading 4.7% below its 200 day moving average.

From a valuation standpoint, the stock is 87.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 32.3.

Osteopore Limited's total revenue rose by 102.1% to $832K since the same quarter in the previous year.

Its net income has increased by 13.2% to $-1M since the same quarter in the previous year.

Finally, its free cash flow grew by 46.1% to $-514K since the same quarter in the previous year.

Based on the above factors, Osteopore Limited gets an overall score of 4/5.

Sector	Healthcare
Industry	Medical Instruments & Supplies
Exchange	AU
CurrencyCode	AUD
ISIN	AU0000053324

Market Cap	2M
PE Ratio	None
Target Price	None
Beta	-0.28
Dividend Yield	None

ABOUT

Osteopore Limited

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, the United States, Malaysia, Indonesia, Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. It manufactures and trades medical implants. In addition, it sells medical devices; provides technology services; and engages in research and development activities. Osteopore Limited was founded in 2003 and is headquartered in Singapore.

OSX.AU · Osteopore Limited

-

Osteopore Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Osteopore Limited using a moving average strategy